Several important international oil market information sources

1. Argus Argus Media is a globally leading independent energy price reporting and market analysis firm, offering price assessments, fundamental data, news coverage, market analysis, and consulting services. Website: argusmedia.com 2. OilPrice OilPrice.com is an internationally renowned energy portal whose event analyses, research reports, and real-time news are trusted by professional investors. Website: oilprice.com 3. S&P Global Platts S&P Global Platts—formerly part of The McGraw-Hill Companies—is a global leader in energy and metals information. Its clients span the entire energy and metals supply chain: exploration companies, refineries, power and gas utilities, integrated energy firms, mining companies, pipeline operators, carriers, wholesalers, and industry professionals—all rely on Platts’ intelligence for critical trading, investment, and business decisions. Website: spglobal.com Chinese-language website: platts.cn 4. Rigzone Rigzone is a U.S.-based online portal serving the crude oil and natural gas industry. Website: rigzone.com 5. World Oil World Oil is a specialized crude oil portal offering in-depth event analysis and industry-chain news widely recognized by professional investors. Website: worldoil.com 6. Bloomberg Bloomberg is one of the world’s largest business news agencies. Its press releases, event research analyses, real-time commentary, and special investigations have earned the trust of professional investors—and Bloomberg terminals are indispensable tools for investment professionals. Compared with Reuters, Bloomberg focuses more intensively on business and economic news; compared with Dow Jones, Bloomberg’s reporting is broader in scope and deeper in analysis. Bloomberg is also known as “Bloomberg,” “Bloomberg News,” or “Bloomberg L.P.” Leveraging its information and data advantages, Bloomberg offers the “Bloomberg Terminal”—a must-have investment assistant for professional investors.

Revealing the State-Owned Capital Investment Strategy in Healthcare: 15 healthcare funds, nearly 70 projects, with key focus areas including biopharmaceuticals, tech-enabled healthcare, and genomics

From the perspective of investment sectors, state-owned capital primarily targets biopharmaceuticals, medical devices, genomics, and AI-powered healthcare—while showing minimal involvement in the ‘Internet + Healthcare’ sector. This reflects the distinct investment logic of state-owned capital: it favors long-term, sustained investments aimed at industrial guidance or support. When cutting-edge technologies or innovative business models emerge, they typically require time to demonstrate scalability and commercial viability—precisely when state-owned capital steps in. From the perspective of investment stage, state-owned capital predominantly participates from Series A onward—meaning it prefers enterprises already validated by market performance and private capital. Another notable feature is the relatively large scale of its investments, often reaching tens or even hundreds of millions of RMB. This aligns closely with the nature of its target sectors: biopharmaceuticals, medical devices, and genomics demand substantial upfront R&D investment and extended development timelines—thus requiring correspondingly larger and longer-term capital commitments. Profiles of Selected State-Owned Capital Funds The above overview outlines state-owned capital’s participation in the healthcare and life sciences sector. To deepen understanding of its investment patterns, we further introduce several representative state-owned capital funds and their portfolio companies—offering granular insights into investment logic and industrial innovation. The selected funds are: China State-Owned Capital Venture Fund, Guoke Jiahe Fund, and SDIC Innovation & SDIC Entrepreneurship. China State-Owned Capital Venture Fund Officially named China State-Owned Capital Venture Fund Co., Ltd., this fund was established in August 2016 in Qianhai, Shenzhen. Initiated and controlled by China Reform Holdings Corporation (CRHC), it was jointly founded with China Postal Savings Bank, China Construction Bank, and Shenzhen Investment Holding Company. With an initial fund size of RMB 100 billion—and a planned total scale of RMB 200 billion—it focuses on supporting technological innovation and industrial upgrading within central SOEs, amplifying the leverage and influence of state-owned capital while catalyzing broader social investment. Since its inception, the fund has completed multiple landmark investments—including United Imaging Healthcare, Megvii (Face++), 3DMed (Suide Biotech), Cambricon Technologies, and Hihonor Holdings. Guoke Jiahe Fund Established in 2011, Guoke Jiahe Fund is an equity investment fund manager initiated by China Science and Technology Holding Co., Ltd. (“CASTECH”)—acting as the cornerstone investor—and co-founded with several major domestic enterprise groups. It operates as a first-tier subsidiary directly managed by CASTECH. Leveraging the Chinese Academy of Sciences’ world-class technical capabilities, extensive high-tech commercialization outcomes, and strong government and industry resources, Guoke Jiahe combines rich investment management experience with a professional team to focus on emerging sectors such as information technology (TMT) and life sciences—particularly targeting early- and growth-stage high-tech startups possessing proprietary technological barriers. Since its founding, Guoke Jiahe has invested across healthcare and life sciences in companies including Biomarker Bio, Guoke Hengtai, Leyue Information, Lianxin Medical, Argus, KBP Biosciences, Gaimi Technology, Novoheart, Titanium Robotics, and Xukang Medical. SDIC Innovation & SDIC Entrepreneurship SDIC Innovation Investment Management Co., Ltd., founded in 2009, is a professional private equity management firm operating independently under market-oriented principles. SDIC Innovation currently manages over RMB 50 billion in fund assets—either directly or indirectly—including capital from financial institutions, the national social security fund, and both state-owned and private entities—making it one of China’s largest professional private equity management firms.

Argus Lowers Koppers Holdings Price Target to $47.00

1 day ago

Argus Research lowered its price target for Koppers Holdings to $47.00 as the stock trades at $43.32. The company manufactures treated wood products, wood-preservation chemicals, and carbon compounds ahead of upcoming Q3 earnings.

ad-hoc-news.de

2026-03-30

Koppers Holdings Inc Stock Marks 20th NYSE Anniversary with Closing Bell Ceremony Amid Strategic Growth

2026-03-31

Koppers to Ring NYSE Closing Bell for 20th Listing Anniversary

2026-03-31

Koppers Holdings Inc PE Ratio & Valuation Analysis

2026-04-16

Koppers Holdings Inc. (NYSE:KOP) Short Interest Update

2026-04-18

Koppers Holdings Inc Stock (US5006051061): Why Its Carbon Materials Positioning Is Suddenly Worth a Closer Look